Form Type: 4

SEC EDGAR Link
Accession Number:0001209191-20-037229
Date:2020-06-15
Issuer: KARYOPHARM THERAPEUTICS INC. (KPTI)
Original Submission Date:

Reporting Person:

KAUFFMAN MICHAEL
C/O KARYOPHARM THERAPEUTICS INC.
85 WELLS AVENUE NEWTON, MA 02459

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2020-06-15 M 7,143 a $0.03 763,632 indirect
COMMON STOCK 2020-06-15 S 7,143 d $16.38 756,489 indirect
COMMON STOCK 2020-06-15 M 357 a $0.03 756,846 indirect
COMMON STOCK 2020-06-15 S 357 d $16.20 756,489 indirect
COMMON STOCK 2020-06-15 0 $0.00 555,122 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
STOCK OPTION (RIGHT TO BUY) 0.033 2020-06-15 deemed execution date M 7,143 (d) 2020-10-31 common stock 7,143 $0.03 16,424 indirect by spouse
STOCK OPTION (RIGHT TO BUY) 0.033 2020-06-15 deemed execution date M 357 (d) 2020-10-21 common stock 357 $0.03 0 indirect by spouse
Footnotes
IDfootnote
f1 these transactions were effected pursuant to a rule 10b5-1 trading plan adopted by the spouse of the reporting person.
f2 represents the weighted average sale price. these shares were sold in multiple transactions at prices ranging from $16.12 to $16.58, inclusive. the spouse of the reporting person undertakes to provide upon request by the u.s. securities and exchange commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
f3 this option, representing a right to purchase a specified number of shares, vested as to 25% of the shares on november 1, 2011, and the remaining 75% vested in 36 equal monthly installments thereafter.
f4 this option, representing a right to purchase a specified number of shares, vested as to 25% of the shares on october 22, 2011, and the remaining 75% vested in 36 equal monthly installments thereafter.
WhaleWisdom Logo

Elevate your investments